Supplementary Materials and Methods; Supplementary Figures S1-S5; and Supplementary Tables S1-S5 from α&lt;sub&gt;V&lt;/sub&gt;β&lt;sub&gt;3&lt;/sub&gt; Integrin-Targeted Radionuclide Therapy with &lt;sup&gt;64&lt;/sup&gt;Cu-cyclam-RAFT-c(-RGDfK-)&lt;sub&gt;4&lt;/sub&gt;